Ongoing trade alerts, surfaced by Ghostworks Intelligence and posted as they happen. Discretionary calls to evaluate yourself -- not financial advice.
Shares of Citizens, Inc. have rolled over from a recent high and continue to show renewed selling pressure on above-average volume. The stock's short-term trend has turned decisively lower, with sellers stepping in on each attempted bounce and momentum failing to turn positive. Down days have outpaced up days in volume, a pattern consistent with sustained distribution rather than a temporary pullback. With an Edge Score of 71, this setup ranks among the stronger bearish swing candidates in today's scan, offering traders a favorable reward relative to risk for a short position held over a multi-day to multi-week horizon.
This information is provided for educational purposes only and does not constitute financial advice. Trading involves substantial risk of loss. Past performance is not indicative of future results. Always conduct your own research and consult a licensed financial advisor before making any trading decisions.
ZipRecruiter's uptrend, which took hold in the wake of its last earnings report, cooled off for a stretch before shares found their footing and have now rallied for four straight sessions on above-average volume. That kind of sustained buying interest across multiple sessions suggests the bounce has real support behind it rather than being a single-day pop. Trend and momentum both look constructive here, and the stop reference sits below the recent low that marked the pullback's bottom, keeping the risk well defined relative to entry.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
BBB Foods gapped higher following its latest earnings report and has spent the six sessions since consolidating in a tight range just above that level, a pattern that often points to shares being accepted at the new, higher price. Volume on the initial gap day came in at nearly double the recent average, underscoring real interest behind the move. The stop reference sits below the base that's formed since the gap, keeping the invalidation point close to current price relative to the size of the move so far. Momentum remains constructive, and the tightness of the recent range suggests sellers haven't been eager to step in.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Precigen pushed through a ceiling that had capped the stock during its recent consolidation, a level tracing back to the high set in the wake of an earnings pop, and shares promptly notched a fresh 52-week high on the move. Volume has been building as the stock advances, a sign that buying interest is picking up rather than fading as new highs are made. The stop reference sits beneath the consolidation range that preceded the breakout, keeping the invalidation point tied to a level that had held for weeks, while both targets extend that same distance above current price.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Kaspi.kz broke out following a strong earnings report and has held above the old ceiling for nine straight sessions since, a sign the move has staying power rather than fading quickly. Shares have pushed on to a fresh 52-week high, and momentum has been running hot enough that a bit of near-term digestion wouldn't be unusual before the next advance. The stop reference sits below the zone that had capped the stock previously, keeping the invalidation point at a level that would meaningfully change the picture if breached. Price action since the breakout has stayed orderly, without the kind of sharp give-back that would raise concern.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Telix Pharmaceuticals cleared a level that had been marking its recent high, pushing through after a shallow pullback held above support and buyers stepped back in with force. The move came on volume roughly triple the recent average, a strong sign that real participation is behind the breakout rather than a handful of thin trades. Trend strength and momentum both read constructively here, supporting the case for continuation while shares hold above the breakout zone. The stop reference sits back under the area that had been defended during the pullback, keeping the risk defined close to current levels.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Mako Mining has continued to grind higher in the days since its last earnings report, and this isn't a one-day pop — shares dipped modestly afterward, held their footing, and have since pushed on to new highs. That follow-through is notable given the initial reaction to the report was mixed, and the stock's ability to shrug that off and keep climbing speaks to underlying demand. Volume on the latest push higher came in above the recent average. The stop reference sits below the pullback low that held during the shallow dip, keeping the invalidation point reasonably close to current price.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Corcept Therapeutics remains locked in a powerful, accelerating uptrend, and a pullback of roughly ten percent earlier in the run turned out to be little more than a pause before buyers pushed the stock back out to fresh highs. Momentum here has been running hot for some time, and it's starting to look a bit stretched, which leaves less cushion than usual before the move could take a breather. The stop reference sits below the low of that recent pullback, anchoring the invalidation point at a level that held on the last test, while both targets are spaced out using that same distance projected higher.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
10x Genomics broke out of a multi-session base that had formed in the wake of its last earnings report, pushing shares to a fresh 52-week high. Trend strength is exceptionally firm right now, among the stronger reads on the board, and momentum is running warm without yet looking overextended. Volume on the move came in above average, adding some weight behind the breakout. Because this name tends to swing more than most, the stop reference sits meaningfully further from current price than is typical, which keeps the setup valid through more routine chop but also means the distance to invalidation is wider than usual.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Biolife Solutions broke out above a ceiling that had capped a couple weeks of consolidation, with the move still fresh — only a day or two old — and not yet meaningfully retested, so there's a bit more false-breakout risk here than in a setup that's already proven itself. Trend strength registered as exceptionally strong on this one, among the most forceful reads on the board, and momentum is running warm after the push. Volume on the breakout was only modestly above average, which tempers conviction slightly given how new the move is. The stop reference sits below the former resistance-turned-support zone, with both targets spaced out using that same distance to the upside.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Sophia Genetics broke out above a ceiling that had capped the stock during a recent stretch of consolidation, pushing shares to a fresh 52-week high. Trend strength here is elevated, and momentum has run hot enough that the move looks a bit stretched in the near term, so some chop or a pause wouldn't be surprising before the next leg higher. Volume built steadily through the move, coming in above the recent average and lending some conviction to the breakout. The stop reference sits below the former ceiling, keeping the invalidation point close to current price, while both targets are spaced out using that same distance projected higher.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Bio-Rad Laboratories broke out above a level that had been resistance and has held that ground through a subsequent retest, a constructive sign for the move. Trend strength is solid, and momentum is running warm — the stock is pushing into extended territory after its recent run, so upside from here may come in fits and starts rather than a straight line. Volume on the move was only modestly above the recent average, a bit less emphatic than some other setups on the board. The stop reference sits below the retested support zone, with both targets spaced out using that same distance to the upside.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Hirequest surged following its latest earnings report, then gave back a portion of that move before finding buyers and resuming its climb. Trend strength here is very strong, among the firmer reads on the board today, and the bounce off support looked constructive. Worth noting: average daily dollar volume is fairly light for this name, so liquidity is more modest than some other tickers on this list, and price can move more per share traded on lighter volume. The stop reference sits below the level that held on the pullback, with both targets spaced out using that same distance to the upside.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Caesarstone has broken out above a level that had capped the stock for several months, and the subsequent pullback to retest that zone held firmly, a good sign for continuation. Trend strength is running strong here, and momentum is warm — leaning toward overbought — after the recent push, though the successful retest adds some confidence in the level. Volume on the move came in roughly two-thirds above the recent average, showing real participation behind the breakout. The stop reference sits just under the retested support area, keeping risk relatively contained.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.
Iovance Biotherapeutics broke out to fresh 52-week highs and has held above the breakout zone, with volume running more than double the recent average on the move. Trend strength is elevated and buyers have been firmly in control, though the stock is pushing into extended territory after such a sharp advance, so some near-term cooling or chop wouldn't be surprising even within an intact uptrend. The stop reference sits just below the area that supported the breakout, keeping the invalidation point relatively tight, while both targets are set using that same distance projected higher.
Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.